Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of cognitive function and mobility in individuals with everyday pain treated with Panadol
2015-002330-42Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of acetaminophen and paracetamol + caffeine in acute pain (2 arms), sponsored by GSK. Primary endpoint: Change in cognitive function from pain-free state. Started Oct 2019; status: completed.
02
Drugs
acetaminophenparacetamol + caffeine
03
Conditions
acute pain
Beyond the preview
Go deeper on 2015-002330-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002330-42.